Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapy.
Wenpei FanNan LuZheyu ShenWei TangBo ShenZhaowen CuiLingling ShanZhen YangZhantong WangOrit JacobsonZijian ZhouYijing LiuPing HuWeijing YangJibin SongYang ZhangLiwen ZhangNiveen M KhashabMaria A AronovaGuangming LuXiaoyuan Shawn ChenPublished in: Nature communications (2019)
The success of radiotherapy relies on tumor-specific delivery of radiosensitizers to attenuate hypoxia resistance. Here we report an ammonia-assisted hot water etching strategy for the generic synthesis of a library of small-sized (sub-50 nm) hollow mesoporous organosilica nanoparticles (HMONs) with mono, double, triple, and even quadruple framework hybridization of diverse organic moieties by changing only the introduced bissilylated organosilica precursors. The biodegradable thioether-hybridized HMONs are chosen for efficient co-delivery of tert-butyl hydroperoxide (TBHP) and iron pentacarbonyl (Fe(CO)5). Distinct from conventional RT, radiodynamic therapy (RDT) is developed by taking advantage of X-ray-activated peroxy bond cleavage within TBHP to generate •OH, which can further attack Fe(CO)5 to release CO molecules for gas therapy. Detailed in vitro and in vivo studies reveal the X-ray-activated cascaded release of •OH and CO molecules from TBHP/Fe(CO)5 co-loaded PEGylated HMONs without reliance on oxygen, which brings about remarkable destructive effects against both normoxic and hypoxic cancers.
Keyphrases
- metal organic framework
- high resolution
- drug delivery
- early stage
- dual energy
- squamous cell carcinoma
- magnetic resonance imaging
- radiation therapy
- stem cells
- computed tomography
- photodynamic therapy
- bone marrow
- endothelial cells
- radiation induced
- mass spectrometry
- mesenchymal stem cells
- molecularly imprinted
- replacement therapy
- single molecule
- nucleic acid
- rectal cancer
- anaerobic digestion
- recombinant human
- case control